医療/バイオ

★医療/バイオ産業カテゴリーの人気レポート・最新レポートはこちら★

創傷包帯の世界市場2018-2022:従来型、最新型

2018年2月14日 // 0 Comments

About Wound Dressings
Wound dressings are sterile. Sometimes, they contain medication. They are applied to cover a wound or lesion using aseptic technique to promote healing and protect the wound from further harm.

Technavio’s analysts forecast the global wound dressings market to grow at a CAGR of 5.06% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global wound dressings market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Wound Dressings Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Acelity
• Coloplast
• ConvaTec
• Mölnlycke Health Care
• Smith & Nephew
• Integra LifeSciences

[Market driver]
• Increasing prevalence of acute and chronic wounds
• For a full, detailed list, view our report

[Market challenge]
• High cost of wound care treatments
• For a full, detailed list, view our report

[Market trend]
• Increasing demand for combination dressings
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

眼科用光干渉断層撮影(OCT)の世界市場2018-2022:従来型、手持型・統合型

2018年2月14日 // 0 Comments

About Optical Coherence Tomography for Ophthalmology
OCT for ophthalmology helps to diagnose various ophthalmic diseases such as age-related macular degeneration, diabetic retinopathy, and cataract. Spectral-domain technology, swept-source technology, and full-field technology are some of the technologies that are used in the OCT products available in the market.

Technavio’s analysts forecast the global optical coherence tomography for ophthalmology market to grow at a CAGR of 6.85% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global optical coherence tomography for ophthalmology market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Optical Coherence Tomography for Ophthalmology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Carl Zeiss Meditec
• Danaher
• Heidelberg Engineering
• NIDEK
• Optovue
• TOPCON

[Market driver]
• Increasing incidences of ocular diseases
• For a full, detailed list, view our report

[Market challenge]
• High cost associated with OCT
• For a full, detailed list, view our report

[Market trend]
• Growing focus toward adaptive optics
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

分娩後出血 (PPH)用機器の世界市場2018-2022:子宮内バルーンタンポナーデ、使い捨てプレフィルド注入システム

2018年2月14日 // 0 Comments

About Postpartum Hemorrhage (PPH) Devices
PPH is defined as blood loss of more than 500 ml from the genital tract within 24 hours of the vaginal birth of a baby, or 1,000 ml or more after a cesarean delivery. PPH devices are the equipment that is used to manage or limit the uterine blood loss during PPH.

Technavio’s analysts forecast the global postpartum hemorrhage (PPH) devices market to grow at a CAGR of 5.22% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global postpartum hemorrhage (PPH) devices market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Postpartum Hemorrhage (PPH) Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BD
• Cook Medical
• C. R. Bard
• Teleflex
• Utah Medical Products
• ZOEX

[Market driver]
• Increasing incidence of PPH
• For a full, detailed list, view our report

[Market challenge]
• Dearth of maternity healthcare services in developing countries
• For a full, detailed list, view our report

[Market trend]
• Increasing focus on development of alternative PPH treatment devices
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

除細動器の世界市場2018-2022:埋込式除細動器(IDC)、体外式除細動器

2018年2月14日 // 0 Comments

About Defibrillator
Defibrillators are used to deliver therapeutic shock to an individual’s heart during life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The electric shock depolarizes muscles and restores normal rhythm of the heart.

Technavio’s analysts forecast the global defibrillator market to grow at a CAGR of 7.12% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global defibrillator market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Defibrillator Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BIOTRONIK
• Boston Scientific
• Medtronic

[Market driver]
• Rising prevalence of CVDs
• For a full, detailed list, view our report

[Market challenge]
• Increasing pricing pressure on vendors
• For a full, detailed list, view our report

[Market trend]
• Technological advances
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

嚢胞性繊維症治療薬の世界市場2018-2022:CFTRモジュレーター、粘液溶解薬、膵酵素補充薬、抗感染薬、気管支拡張薬

2018年2月14日 // 0 Comments

About Cystic Fibrosis Therapeutics
CF is a genetic disorder that mostly affects the lungs and sometimes other parts of the body such as the liver, pancreas, intestines, and the kidneys. The disease is inherited in an autosomal recessive manner. It is due to mutations caused in both the copies of the gene for the CFTR protein.

Technavio’s analysts forecast the global cystic fibrosis therapeutics market to grow at a CAGR of 17.28% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Cystic Fibrosis Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AbbVie
• Gilead
• F. Hoffmann-La Roche
• Vertex Pharmaceuticals

[Market driver]
• Improved diagnostic technologies
• For a full, detailed list, view our report

[Market challenge]
• Drug discontinuation
• For a full, detailed list, view our report

[Market trend]
• Strategic collaborations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

胃内視鏡の世界市場2018-2022:軟胃内視鏡、硬胃内視鏡

2018年2月14日 // 0 Comments

About GastroscopesGastroscopes are specially designed tubes fitted with lenses and lights that can be passed into the stomachto examine its interior anatomy. Gastroscopes are maneuverable and capture high-quality images and videos of the stomach and the upper GI tract.

Technavio’s analysts forecast the global gastroscopes market to grow at a CAGR of 5.81 % during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global gastroscopes market for 2018-2022. To calculate the market size, the report considers the diagnosis of diseases of the esophagus, stomach, or the upper part of the small intestine (SI).

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Gastroscopes Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Endomed Systems
• FUJIFILM
• HOYA
• HUGER Medical Instrument
• KARL STORZ
• Olympus

[Market driver]
• Wide prevalence of GI disorders
• For a full, detailed list, view our report

[Market challenge]
• Complications and maintenance issues associated with gastroscopes
• For a full, detailed list, view our report

[Market trend]
• Increasing growth opportunities in emerging markets
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

泌尿器科装置の世界市場2018-2022:腎不全、UI管理、BPH治療、尿路結石症、その他

2018年2月14日 // 0 Comments

About Urology DevicesUrology devices are the medical devices that are used for thetreatment of human urinary tract systems and male reproductive organ disorders. The urology devices include dialysis systems and dialysis catheters, ureteroscopes, resectoscopes, ureteral stents, lithotripsy devices, laser fibers, stone retrieval devices, radiofrequency ablation devices, meshes, ureteral access sheaths, balloons, and urinary catheters.

Technavio’s analysts forecast the global urology devices market to grow at a CAGR of 5.08 % during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global urology devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of urology devices.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Urology Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Baxter
• B. Braun Melsungen
• Boston Scientific
• C. R. Bard
• Fresenius Medical Care
• Olympus Corporation

[Market driver]
• Increasing prevalence of urological diseases
• For a full, detailed list, view our report

[Market challenge]
• Limitations and risk factors associated with urology devices
• For a full, detailed list, view our report

[Market trend]
• Emergence of innovative technologies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

母乳パッドの世界市場2018-2022:再利用可能、使い捨て、シリコン製、ハイドロゲル

2018年2月14日 // 0 Comments

About Nursing Breast PadsNursing breast pads are breast milk absorbent pads, which can be slipped inside a bra, to keep the area dry and prevent leakages from discharge through bras and other outer garments. They come in different types, which can either be disposed of or reused based on the material used.

Technavio’s analysts forecast the global nursing breast pads market to grow at a CAGR of 7.48% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global nursing breast pads market for 2018-2022. To calculate the market size, the report considers the revenue generated through the retail sales of different types of nursing breast pads that are used by either individual users or in hospitals.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Nursing Breast Pads Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Ameda
• Koninklijke Philips
• Lansinoh
• Medela
• NUK
• Pigeon

[Market driver]
• Increasing number of working women worldwide
• For a full, detailed list, view our report

[Market challenge]
• Availability of cheaper substitutes
• For a full, detailed list, view our report

[Market trend]
• New product launches with better technologies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

性感染症検査の世界市場2018-2022:研究施設検査、ポイントオブケア(POC)検査

2018年2月14日 // 0 Comments

About Sexually Transmitted Diseases Testing
STDs, also known as STIs, are infectious diseases caused by bacteria, yeast, parasites, and viruses, and are transmitted through sexual contact, thus generating the need for STD testing and demand for devices used for testing.

Technavio’s analysts forecast the global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global sexually transmitted diseases testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Sexually Transmitted Diseases Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• bioMerieux
• Bio-Rad Laboratories
• F. Hoffmann La Roche

[Market driver]
• Rise in STDs
• For a full, detailed list, view our report

[Market challenge]
• Lack of trained professionals
• For a full, detailed list, view our report

[Market trend]
• High demand for POC testing
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

顕微解剖の世界市場2018-2022:学術研究センター、医薬品・バイオテクノロジー企業、その他

2018年2月14日 // 0 Comments

About Microdissection
Microdissection is a technique to isolate cells and tissues from chromosomes using a fine glass needle or laser light under a microscope. Research analysis on the global microdissection market identifies that the growing adoption of next-generation sequencing (NGS) will be one of the major factors that will have a positive impact on the growth of the market. The application of technologically advanced NGS help researchers to analyse multiple genomes at a time, whereas the conventional methods of sequencing such as Sanger sequencing helps in the analysis of one gene at a time.

Technavio’s analysts forecast the global microdissection market to grow at a CAGR of 9.45% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global microdissection market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Microdissection Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Leica Microsystems
• Molecular Machines & Industries
• Thermo Fisher Scientific
• Zeiss international

[Market driver]
• All-inclusive cost structure of sequencing and related products drives R&D
• For a full, detailed list, view our report

[Market challenge]
• Lack of skilled technicians
• For a full, detailed list, view our report

[Market trend]
• Rise in industry-based research collaborations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

医療美容の世界市場2018-2022:体型修正、ボトックス、皮膚充填剤(フィラー)、歯科インプラント、皮膚表面修復、生理食塩水バッグを用いた乳房インプラント

2018年2月14日 // 0 Comments

About Medical AestheticsThe global medical aesthetics market is a contributing segment of the global medical devices market. From a top-down perspective, Technavio has analyzed the medical devices market as a related market to set the context, in which the global medical aesthetics market will be analyzed. The medical devices market comprises all the instruments, machines, implants, or in vitro reagents, which are used in diagnosis, mitigation, treatment, or prevention of any disease. It is a highly diversified market in terms of products and technologies involved. Regulatory organizations such as the US Food and Drug Administration (FDA) assess medical devices as per a pre-defined medical device development tool (MDDT) program. The MDDT is used to qualify tools that medical device manufacturers or sponsors can use in the development and evaluation of the safety of medical devices.

Technavio’s analysts forecast the global medical aesthetics market to grow at a CAGR of 7.29% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global medical aesthetics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of medical aesthetics.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Medical Aesthetics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• Dentsply Sirona
• Galderma
• Johnson & Johnson
• Merz Pharma
• Valeant Pharmaceuticals

[Other prominent vendors]
• 3M
• ADIN Dental Implant Systems
• Alma Lasers
• BioHorizons
• Biotech Dental
• Cutera
• Danaher
• Deka Laser Technologies
• Dentsply Sirona
• Hangzhou Techderm Biological Products
• Hologic
• HI-TEC IMPLANTS
• Lumenis
• NDI Dental Implants
• OSSTEM IMPLANT
• Photomedex
• SciVision Biotech
• SGS Dental
• Sinclair Pharma
• Southern Implants
• Straumann
• Suneva Medical
• Syneron Medical
• Sweden & Martina
• TRI Dental Implants
• YOLO Medical
• Zimmer Biomet
• Zimmer MedizinSysteme.

[Market driver]
• Rapid advantages in technology
• For a full, detailed list, view our report

[Market trend]
• Increasing global awareness about medical aesthetics
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

免疫の世界市場2018-2022:自己免疫疾患、腫瘍学、臓器移植、その他

2018年2月14日 // 0 Comments

About ImmunologyThe immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body’s healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body’s defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body’s cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

Technavio’s analysts forecast the global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AbbVie
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson

[Other prominent vendors]
• Angimmune
• Bionor Pharma
• Boston Biomedical
• Celgene
• Cellectar Biosciences
• eFFECTOR Therapeutics
• Forty Seven
• HANSOH
• Immatics Biatechnologies
• lmmunovaccine
• Karyopharm Therapeutics
• MabVax Therapeutics
• MedImmune
• MOLOGEN
• Neon Therapeutics
• NewLink Genetics
• Novartis
• ONCOQUEST
• Oncotherapeutics.

[Market driver]
• Growing cases of infectious diseases
• For a full, detailed list, view our report

[Market trend]
• Significant pipeline
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

黄熱:パイプラインインサイト2018

2018年2月9日 // 0 Comments

“Yellow Fever – Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Yellow Fever development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Yellow Fever
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Yellow Fever
The report assesses the active Yellow Fever pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Yellow Fever
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Yellow Fever
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Yellow Fever
• The report also covers the dormant and discontinued pipeline projects related to the Yellow Fever

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Yellow Fever to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Yellow Fever therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

乾燥症:パイプラインインサイト2018

2018年2月9日 // 0 Comments

“Xerosis – Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Xerosis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Xerosis
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Xerosis
The report assesses the active Xerosis pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Xerosis
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Xerosis
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Xerosis
• The report also covers the dormant and discontinued pipeline projects related to the Xerosis

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Xerosis to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Xerosis therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

滲出型加齢黄斑変性症:パイプラインインサイト2018

2018年2月9日 // 0 Comments

“Wet Macular Degeneration – Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Wet Macular Degeneration development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Wet Macular Degeneration
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Wet Macular Degeneration
The report assesses the active Wet Macular Degeneration pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Wet Macular Degeneration
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Wet Macular Degeneration
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Wet Macular Degeneration
• The report also covers the dormant and discontinued pipeline projects related to the Wet Macular Degeneration

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Wet Macular Degeneration to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Wet Macular Degeneration therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1 2 3 4 5 6 28